JP2002506014A - 新規な避妊用キット - Google Patents

新規な避妊用キット

Info

Publication number
JP2002506014A
JP2002506014A JP2000535302A JP2000535302A JP2002506014A JP 2002506014 A JP2002506014 A JP 2002506014A JP 2000535302 A JP2000535302 A JP 2000535302A JP 2000535302 A JP2000535302 A JP 2000535302A JP 2002506014 A JP2002506014 A JP 2002506014A
Authority
JP
Japan
Prior art keywords
contraceptive
steroid
steroid compound
compound
structural formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000535302A
Other languages
English (en)
Japanese (ja)
Inventor
クローステルブール，ヘレニウス・ヤン
デケルス，ホーデフリドス・ヘルマヌス・ヨハンナ
ハーメルスマ，ヨハンネス・アントニウス・マリア
フエルボスト，ピーテル・ミヒエル
クーリニグ・ベンニンク，ヘルマン・ヤン・テイメン
Original Assignee
アクゾ・ノベル・エヌ・ベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクゾ・ノベル・エヌ・ベー filed Critical アクゾ・ノベル・エヌ・ベー
Publication of JP2002506014A publication Critical patent/JP2002506014A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP2000535302A 1998-03-09 1999-03-03 新規な避妊用キット Withdrawn JP2002506014A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98200744.5 1998-03-09
EP98200744 1998-03-09
PCT/EP1999/001404 WO1999045886A2 (en) 1998-03-09 1999-03-03 New contraceptive kit for monotherapy

Publications (1)

Publication Number Publication Date
JP2002506014A true JP2002506014A (ja) 2002-02-26

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000535302A Withdrawn JP2002506014A (ja) 1998-03-09 1999-03-03 新規な避妊用キット

Country Status (20)

Country Link
EP (1) EP1061928A2 (de)
JP (1) JP2002506014A (de)
KR (1) KR20010041698A (de)
CN (1) CN1292702A (de)
AR (1) AR018313A1 (de)
AU (1) AU756882B2 (de)
BR (1) BR9908605A (de)
CA (1) CA2319765A1 (de)
CO (1) CO5070598A1 (de)
HU (1) HUP0101007A3 (de)
ID (1) ID25621A (de)
IL (1) IL137541A0 (de)
NO (1) NO20004492D0 (de)
NZ (1) NZ506115A (de)
PE (1) PE20000330A1 (de)
PL (1) PL343428A1 (de)
RU (1) RU2225714C2 (de)
TR (1) TR200002593T2 (de)
WO (1) WO1999045886A2 (de)
ZA (1) ZA991851B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051214A2 (en) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
NZ517281A (en) 1999-09-06 2003-09-26 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
KR20030029640A (ko) 2000-07-28 2003-04-14 악조 노벨 엔.브이. 16 알파-메틸 또는 에틸 치환 에스트로겐
EP1485103A1 (de) * 2002-03-11 2004-12-15 Janssen Pharmaceutica N.V. Kontinuierliches sulfatase-hemmendes progestogen enthaltendes kontrazeptionsschema
WO2003077927A1 (en) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
NO20004492L (no) 2000-09-08
AU3143799A (en) 1999-09-27
BR9908605A (pt) 2001-04-24
HUP0101007A3 (en) 2002-02-28
NO20004492D0 (no) 2000-09-08
ID25621A (id) 2000-10-19
AU756882B2 (en) 2003-01-23
PL343428A1 (en) 2001-08-13
ZA991851B (en) 1999-09-22
CN1292702A (zh) 2001-04-25
AR018313A1 (es) 2001-11-14
CA2319765A1 (en) 1999-09-16
PE20000330A1 (es) 2000-05-16
HUP0101007A2 (hu) 2001-12-28
TR200002593T2 (tr) 2000-12-21
RU2225714C2 (ru) 2004-03-20
KR20010041698A (ko) 2001-05-25
WO1999045886A2 (en) 1999-09-16
IL137541A0 (en) 2001-07-24
EP1061928A2 (de) 2000-12-27
WO1999045886A3 (en) 1999-12-02
NZ506115A (en) 2003-07-25
CO5070598A1 (es) 2001-08-28

Similar Documents

Publication Publication Date Title
JP4023820B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体を含有する医薬製剤
CA2135608C (en) Contraception using competitive progesterone antagonists, and novel compounds useful therefor
JP3814292B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体、これらの製造方法及びこれら化合物を含有する製薬組成物
JP4368945B2 (ja) 新規１９―ノループレグネン誘導体類
WO2013064620A1 (de) 18-METHYL-6,7-METHYLEN-3-OXO-17-PREGN-4-EN-21,17β-CARBOLACTONE, PHARMAZEUTISCHE PRÄPARATE ENTHALTEND DIE GENANNTEN VERBINDUNGEN UND DEREN ANWENDUNG BEI DER THERAPIE DER ENDOMETRIOSE
JP2000502108A (ja) ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット
JP2002541126A (ja) 低用量エストロゲン断続的ホルモン補充療法
JP2002506014A (ja) 新規な避妊用キット
JP3026997B2 (ja) １９―ノルステロイドから導かれる基が芳香族核上に置換している新規なω―フェニルアミノアルカン酸及びそれらの塩類、これらの製造法、この製造法の新規な中間体、これらの薬剤としての使用並びにこれらを含有する組成物
CA2384184C (en) 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
JP2007210994A (ja) ステロイド類、それらの調製、それらの薬学的組成物およびこの化合物の使用
JP6486900B2 (ja) プロゲステロン受容体アンタゴニスト剤形
US6987101B1 (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
JP2000515889A (ja) プロゲスチンとエストロゲンとの混合剤からなる二相性避妊法およびキット
MXPA00008814A (en) New contraceptive kit
CZ20003285A3 (cs) Antikoncepční sada
WO2005100376A1 (de) 17α-FLUOR 17β-HYDROXIMINOMETHYL-STEROIDE, EIN VERFAHREN ZU DEREN HERSTELLUNG UND DIESE VERBINDUNG ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
EP2773356A1 (de) 18-methyl-6,7-methylen-3-oxo-17-pregn-4-en-21,17 -carbolactone, pharmazeutische präparate enthaltend die genannten verbindungen und deren anwendung bei der therapie der endometriose
JP2002543136A (ja) 併用療法における抗プロゲスタゲンの使用
DE1966504A1 (de) Oral wirksames konzeptionsverhinderndes mittel
DE1966505A1 (de) Oral wirksames ovulations-verhinderndes mittel

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060509